Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) News, Nityr Cycle Pharmaceuticals launches SAJAZIR TM (icatibant) Injection, a new treatment option in Hereditary Angioedema (HAE) By Holly Archer|2021-09-28T11:36:58+01:00September 28th, 2021|News, Nityr| Read More
Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients News, Nityr Cycle Pharmaceuticals Launches Cycle Vita™, a dedicated support platform for rare disease patients By Holly Archer|2021-09-14T16:56:52+01:00September 10th, 2021|News, Nityr| Read More
